Global Discovery Stage Partnering Deals and Agreements Analysis Report 2010-2017
Comunicato Precedente
Comunicato Successivo
The report provides a detailed understanding and analysis of how, why and on what terms companies enter discovery stage partnering deals. These deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors product or technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of all discovery stage partnering deals announced since 2010 including financial terms where available including over 3,000 links to online deal records of actual discovery partnering deals as disclosed by the deal parties.
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2017 include:
The available contracts are listed by:
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Why do companies partner at discovery stage?
Chapter 3 - Discovery stage deal strategies and structure
Chapter 4 - Discovery stage partnering payment strategies
Chapter 5 - Trends in discovery stage deal making
Chapter 6 - Payment terms for discovery stage partnering
Chapter 7 - Leading discovery stage deals
Chapter 8 - Top 50 most active discovery stage dealmakers
Chapter 9 - Discovery stage partnering contracts directory
Chapter 10 - Discovery stage deal making by development stage
For more information about this report visit https://www.researchandmarkets.com/research/6wlg8q/global_discovery
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
